Search

Your search keyword '"Rishi Jain"' showing total 40 results

Search Constraints

Start Over You searched for: Author "Rishi Jain" Remove constraint Author: "Rishi Jain" Topic internal medicine Remove constraint Topic: internal medicine
40 results on '"Rishi Jain"'

Search Results

1. Pathologic Complete Response in Patient With ATM Mutation After Neoadjuvant FOLFOXIRI Plus Panitumumab Therapy for Locally Advanced Colon Cancer: A Case Report

2. Psychological distress in patients with metastatic cancer enrolling on phase I clinical trials

Catalog

Books, media, physical & digital resources

3. Toxicity and outcomes in older versus younger patients treated with trimodality therapy for locally advanced rectal cancer

4. NCCN Guidelines Insights: Colorectal Cancer Screening, Version 2.2020

5. Open-label, Phase I Study of Nivolumab Combined with nab-Paclitaxel Plus Gemcitabine in Advanced Pancreatic Cancer

6. Six Months Comparative Evaluation of Efficacy and Safety of Wockhardt's Biosimilar Insulin Glargine (Glaritus®) with Reference Insulin Glargine (Lantus®) in Type 2 Diabetes Mellitus in India: Results of Interim Analysis

7. Treatment-related toxicity and outcomes in older versus younger patients with esophageal cancer treated with neoadjuvant chemoradiation

8. An open labelled prospective clinical study to evaluate the efficacy, safety and cost analysis of Pidotimod as add-on drug for maintenance therapy in Paediatric Recurrent Acute Respiratory tract Infections

9. A Prospective, Randomized, Open Label, Single-Centre Study for Assessment of Safety and Effectiveness of Recombinant Human Insulin 30/70 + Insulin Glulisine compared to Recombinant Human Insulin NPH + Regular in the Management of Type 2 Diabetes Mellitus Patients in the Philippines

10. Refining Immunotherapy for the Treatment of Gastric Cancer With High Microsatellite Instability

11. Impact of Clinical Markers of Nutritional Status and Feeding Jejunostomy Use on Outcomes in Esophageal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy

12. The Role of Malnutrition and Muscle Wasting in Advanced Lung Cancer

13. Methicillin-Resistant Staphylococcus aureus Infections in Patients With Renal Disorders: A Review

14. Immunogenicity, Safety and Efficacy Comparison of Wockhardt’s Biosimilar Insulin Glargine—Glaritus® with Reference Product— Lantus®: Study Protocol & Early Data Trends

15. Salt sensitivity and its implication in clinical practice

16. Pharmacokinetics-directed Intravenous Busulfan Combined With High-dose Melphalan and Bortezomib as a Conditioning Regimen for Patients With Multiple Myeloma

17. 2322-PUB: Consistency and Predictability of Control of Glycemic Variability with U200 (Concentrated r-DNA Human Insulin Premix 30/70 - 200 IU/mL) in Type 2 Diabetes Mellitus Patients

18. 1113-P: Six Months Comparative Evaluation of Efficacy and Safety of Wockhardt’s Biosimilar Insulin Glargine (Glaritus®) with Reference Insulin Glargine (Lantus®) in Type 2 Diabetes Mellitus in India

19. Impact of Baseline Nutrition and Exercise Status on Toxicity and Outcomes in Phase I and II Oncology Clinical Trial Participants

20. Feasibility of using a computerized food frequency questionnaire (FFQ) to assess dietary patterns in patients with advanced gastrointestinal (GI) malignancies

21. Associations between psoas muscle area (PMA) and density (PMD) with phase I oncology clinical trial outcomes

22. Assessing real-world biomarker testing rates in metastatic colon cancer

23. Nutrition and Aging: a Practicing Oncologist's Perspective

24. A non-interventional, prospective, multicentric real life Indian study to assess safety and effectiveness of un-denatured type 2 collagen in management of osteoarthritis

25. Nutrition and exercise patterns in survivors of esophageal and gastroesophageal junction (EGEJ) cancers

26. Clinical Studies Examining the Impact of Obesity on Breast Cancer Risk and Prognosis

27. Prevalence and correlates of critical malnutrition (CMN) among gastrointestinal (GI) and non-GI participants in phase I/II (P1/2) clinical trials

28. Muscle-invasive urothelial bladder cancer: an update on systemic therapy

29. Short Term Safety and Tolerability of a Fixed Dose Combination of Olmesartan, Amlodipine and Hydrochlorothiazide

30. Prevalence of critical malnutrition (CMN) in patients enrolling on phase I/II (P1/2) clinical trials

31. Management of type 2 diabetes mellitus: insights into prescribing trends

32. Renal safety profile of di-peptidyl-peptidase inhibitors: a review of available literature

33. Toxicity and survival in older versus younger esophageal cancer (EC) patients (pts) treated with neoadjuvant chemoradiotherapy (nCRT)

34. Association between markers of malnutrition (MN) and toxicity (T) during neoadjuvant chemoradiotherapy (nCRT) for esophageal cancer (EC)

35. Management of hypertension: Insights into prescribing behavior with focus on angiotensin receptor blockers

36. Changing patterns of metastatic pancreatic cancer (mPC) care in the combination therapy era: A geriatric perspective

37. The risk of second primary cancers in clear cell and papillary renal cancer

38. Anisocytosis Is Associated With Decreased Survival In Patients With Newly Diagnosed Myelodysplastic Syndromes: A Single Center Experience

39. Epidemiologic study of myelodysplastic syndromes in a racially diverse inner-city population

40. Multiplicative Interaction Between Mean Corpuscular Volume and Red Cell Distribution Width in Predicting Mortality of Elderly Patients with and without Anemia